Skip to main content

Table 2 Patients in whom PET/CT showed additional lesions and treatment changes

From: The role of initial 18F-FDG PET/CT in the management of patients with suspected extramedullary plasmocytoma

Case Pre-PET/CT treatment planning

Post-PET/CT treatment planning

Comment

Major treatment changes

 8 Resection of nasal plasmacytoma combined with RT

Resection of nasal plasmacytoma plus RT for nasal cavity and left pubis lesion, chemotherapy was given

More invasive therapy was given, including enlarged field irradiation and systemic therapy

 9 RT for primary EMP in nasopharynx

RT for EMP of nasopharynx and iliac bone lesion, chemotherapy was given

More invasive therapy was given, including enlarged field irradiation and systemic therapy

 12 Resection of thyroid plasmacytoma combined with RT

Resection of thyroid and breast plasmacytomas, RT for surgical margin combined with concomitant chemotherapy

More invasive therapy was given, including surgical region, enlarged field irradiation and systemic therapy

 18 RT for primary EMP in right maxillary sinus

RT for primary EMP in right maxillary sinus combined with concomitant chemotherapy

Systemic therapy was given

Minor treatment changes

 2 RT for primary EMP in nasopharynx and left cervical lymph node metastasis

RT for primary EMP in nasopharynx and bilateral cervical lymph node metastasis

Only enlarged lymphatic field irradiation

 5 RT for left supraclavicular area

RT for supraclavicular and mediastinal area

Only enlarged lymphatic field irradiation

 13 Resection of intestinal plasmacytoma combined with RT

No change

 

 20 RT for left inguinal, bilateral iliac area

RT for left inguinal, bilateral iliac and retroperitoneal area

Only enlarged lymphatic field irradiation

  1. RT radiotherapy, EMP extramedullary plasmocytoma